ACCELERATING DRUG DISCOVERY AND DEVELOPMENT BY CREATING A MORE EFFECTIVE, EFFICIENT FDA

Reform of the drug-review process at the Food and Drug Administration can be achieved by streamlining the process, separating overlapping re gulations, delegating some functions to nongovernmental bodies, and be coming more flexible, contends Karl A. DeSante, senior research scient ist at Lilly Laboratories.